Where it is registered
Each register and historical list with its number of registrations and a few of them.
Canada
Health Canada · 27 registrations
- Intron A6000000 UNIT / ML · Solution · Merck Canada INC
- Intron A50000000 UNIT / ML · Liquid · Merck Canada INC
- Intron A10000000 UNIT / ML · Solution · Merck Canada INC
- Intron A15000000 UNIT / ML · Liquid · Merck Canada INC
United States
FDA · 13 registrations
- Intron A2B 10MIU/VIAL, 2B 18MIU/VIAL, 2B 25MIU/VIAL · vial · Schering
- Intron A18MIU · For Injection · Merck Sharp & Dohme LLC
- Intron A5MIU · Injection · Merck Sharp & Dohme LLC
- Intron A18MIU · Injection · Merck Sharp & Dohme LLC
Spain
AEMPS · 3 registrations
At a glance
- Registers
- 7
- Historical lists
- 2
- Registrations
- 61
- With their own page
- 8
- Companies
- 17
All medicines with Interferon alfa-2b
Human medicines from every register that match Interferon alfa-2b by substance or by name, a page at a time, so the count can differ from the registrations above. Strengths and packs are on each medicine’s page.
70 search results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Intron A | United States | 2B 10MIU/VIAL, 2B 18MIU/VIAL, 2B 25MIU/VIAL | vial | Marketed | Schering |
| Interferon Alfa 2A Humano Recombinante | Brazil | Authorised | Chron Epigen Indústria e Comércio Ltda | ||
| IntronA 18 miljoen IE, oplossing voor injectie in een multidosis pen | Netherlands | Oplossing voor injectie | Authorised | Merck Sharp & Dohme B.V. | |
| IntronA 30 miljoen IE, oplossing voor injectie in een multidosis pen | Netherlands | Oplossing voor injectie | Authorised | Merck Sharp & Dohme B.V. | |
| IntronA 60 miljoen IE, oplossing voor injectie in een multidosis pen | Netherlands | Oplossing voor injectie | Authorised | Merck Sharp & Dohme B.V. | |
| Any | New Zealand | Inj 60 m iu, 1.2 ml multidose pen | Funded | ||
| Any | New Zealand | Inj 30 m iu, 1.2 ml multidose pen | Funded | ||
| Any | New Zealand | Inj 18 m iu, 1.2 ml multidose pen | Funded | ||
| ALFAINTERFERONA 2b | Brazil | Authorised | Fundação Oswaldo Cruz | ||
| Intron-A 10MN IU.Vial | Saudi Arabia | Authorised | Schering-Plough | ||
| Roferon-A 18MN.IU Vial | Saudi Arabia | Authorised | Roche | ||
| Roferon-A 4.5MIU-0.5ML | Saudi Arabia | Authorised | Roche | ||
| Roferon-A 9MIU-0.5ML | Saudi Arabia | Authorised | Roche | ||
| Roferon-A 3MIU-0.5 ML | Saudi Arabia | Authorised | Roche | ||
| RebetolCombination | United States | 200MG, 200MG | capsule | Not marketed | Merck Sharp Dohme |
| Intron A | United States | 18MIU | Injection | Withdrawn | Merck Sharp & Dohme LLC |
| Intron A | United States | 3MIU | Injection | Withdrawn | Merck Sharp & Dohme LLC |
| Intron A | United States | 25MIU | For Injection | Withdrawn | Merck Sharp & Dohme LLC |
| Intron A | United States | 10MIU | Injection | Withdrawn | Merck Sharp & Dohme LLC |
| Intron A | United States | 5MIU | Injection | Withdrawn | Merck Sharp & Dohme LLC |
| Intron A | United States | 5MIU | Injection | Withdrawn | Merck Sharp & Dohme LLC |
| Intron A | United States | 10MIU | Injection | Withdrawn | Merck Sharp & Dohme LLC |
| Intron A | United States | 25MIU | Injection | Withdrawn | Merck Sharp & Dohme LLC |
| Intron A | United States | 18MIU | For Injection | Withdrawn | Merck Sharp & Dohme LLC |
| Intron A | United States | 3MIU | Injection | Withdrawn | Merck Sharp & Dohme LLC |